XNAS · AYTU
0.00% · $0.0000 · Vol 5.7K
After hours · updated 16:00:00 ET
AYTU BioPharma, Inc. Common Stock

AYTU BioPharma, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$2.05
Card
Relationship Map

Follow $AYTU

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $AYTU by email

Veridion Score

BETALOW CONF · 6 of 6 factors measuredMethodology
AYTU
AYTU BioPharma, Inc. Common Stock
Wed Oct 7 · session closed · Markets closed · resumes Thu 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
Middle range · LOW confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6 of 6 factors measured · Wed Oct 7 · session closed · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is AYTU moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading AYTU catalysts
About AYTU BioPharma, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2008
Employees
76
Country
US

Aytu BioPharma Inc is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. It has single operating segment. Its product portfolio includes EXXUA, ADHD Portfolio, Pediatric Portfolio, and Other. Majority of revenue comes from ADHD Portfolio. It has presence in United States.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.04
Day high
$2.10
Day low
$2.03
Previous close
$2.05
52W high
$2.90
-29.31% from high
52W low
$1.94
11% of range
Market cap
$22.3M
Beta
0.45
Shares out
10.9M
Volume
5.7K
0.14× rel vol
Avg volume
42K
VWAP
$2.06
Price history computed in-house
1W
-4.21%
1M
-7.24%
3M
-6.82%
1Y
-13.14%
YTD
-21.15%
SMA 50 $2.21 · below
SMA 200 $2.37 · below
52W position 11%

AYTU overview

Veridion Score
59
Registered · 2026-10-07
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around AYTU.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading AYTU Form 4 filings
Public disclosures

Congress activity in AYTU

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

AYTU contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AYTU in this window.
Lobbying spend

AYTU lobbying filings, year to date.

Registered lobbying filings matched to AYTU BioPharma, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AYTU in this window.
Loading news for AYTU
Analyst ratings
Sovereign unlock shows live analyst consensus for AYTU.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.